The management of glioblastoma in elderly patients with poor performance status (KPS<70) is
unsettled. This single arm phase 2 trial trial was designed to evaluate the efficacy and
safety of temozolomide alone in this population
Phase:
Phase 2
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborators:
Association de Neuro-Oncologues d'Expression Francaise Association de Neuro-Oncologues d’Expression Francaise